Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Given the low prevalence and the heterogeneity of childhood cancers, information about the safety of anti-angiogenic drugs in pediatric patients is only partially assessed. We aimed to evaluate the safety of these drugs in children with solid tumors. This systematic review and meta-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Spini, Andrea, Ciccone, Valerio, Rosellini, Pietro, Ziche, Marina, Lucenteforte, Ersilia, Salvo, Francesco, Donnini, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654149/
https://www.ncbi.nlm.nih.gov/pubmed/36358734
http://dx.doi.org/10.3390/cancers14215315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654149/
https://www.ncbi.nlm.nih.gov/pubmed/36358734
http://dx.doi.org/10.3390/cancers14215315

Ejemplares similares